Concepedia

Author

Fredrik Erlandsson

Karolinska InstitutetORCID

Also Known As

F Erlandsson, F. ERLANDSSON, F. Erlandsson, Fredrik Erlandsson

56

Publications

1.9K

Citations

20

H-Index

56

Concepts

All Affiliations

Karolinska InstitutetAstraZeneca (Sweden)Karolinska University HospitalUppsala UniversityInserm
FE

About

Fredrik Erlandsson is an author at Karolinska Institutet specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

1.2K

2

Engineering

1

1

354

3

Health Sciences

1

1

26

4

Public Health

1

1

51

5

Allergy

1

1

16

Fredrik Erlandsson

×

25

Publications

1.8K

Citations

20

H-Index

YearCitations

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen,

Investigational New Drugs

2013

399

Combining intensity, edge and shape information for 2D and 3D segmentation of cell nuclei in tissue sections

Carolina Wählby, Ida‐Maria Sintorn, Fredrik Erlandsson,

Journal of Microscopy

2004

354

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Silvio Danese, J Rudziński, Wolfgang Brandt,

Gut

2014

151

A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma

Sarah Maria Rudman, Michael B. Jameson, Mark J. McKeage,

Clinical Cancer Research

2011

107

Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei

Carolina Wählby, Fredrik Erlandsson, Ewert Bengtsson,

Cytometry

2001

88

Deletion of the Telomerase Reverse Transcriptase Gene and Haploinsufficiency of Telomere Maintenance in Cri du Chat Syndrome

Anju Zhang, Chengyun Zheng, Mi Hou,

The American Journal of Human Genetics

2003

78

A Detailed Analysis of Cyclin A Accumulation at the G1/S Border in Normal and Transformed Cells

Fredrik Erlandsson, Carolina Linnman, Susanna V. Ekholm,

Experimental Cell Research

2000

73

Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast Cancer

Nuhad K. Ibrahim, Kemal O. Yariz, Alexey Manikhas,

Clinical Cancer Research

2011

69

Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial

Austin G. Stack, Nalina Dronamraju, Joanna Parkinson,

American Journal of Kidney Diseases

2020

68

Validation of the IntelliCap® system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drug

Erik Söderlind, Bertil Abrahamsson, Fredrik Erlandsson,

Journal of Controlled Release

2015

53

Page 1